Maurizio Zanetti

Title(s)Recall Faculty, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    (PQ3) Disruption of immune surveillance by aneuploidy and aberrant MHCII expression
    NIH R01CA220009Aug 17, 2017 - Jul 31, 2022
    Role: Principal Investigator
    Phase 2 Study of Vascular-Targeted Prodrug (G-202) for the Treatment of Recurrent Glioblastoma
    NIH R01FD005077Apr 20, 2015 - Mar 31, 2019
    Role: Principal Investigator
    Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
    NIH R21CA178674Aug 1, 2014 - Feb 28, 2018
    Role: Principal Investigator
    Genetically-Programmed APC Vaccines Against Viruses
    NIH R56AI062894Sep 30, 2011 - Sep 29, 2014
    Role: Principal Investigator
    Genetically-Programmed APC Vaccines Against Viruses
    NIH R01AI062894Feb 1, 2005 - Jan 31, 2009
    Role: Principal Investigator
    Conformationally-Constrained PA Anthrax Vaccine
    NIH R21AI057889Sep 30, 2004 - Aug 31, 2007
    Role: Principal Investigator
    Novel APC Vaccine to Induce Anti-Tumor T cell Immunity
    NIH R01CA092119Jul 1, 2002 - Jun 30, 2007
    Role: Principal Investigator
    Transgenic B-Cell Immunogenes
    NIH R21AI049774May 1, 2001 - Apr 30, 2004
    Role: Principal Investigator
    TARGETED THERAPEUTIC VACCINATION IN PROSTATE CANCER
    NIH R01CA084062Jul 1, 2000 - Jun 30, 2005
    Role: Principal Investigator
    Strategies of Vaccination Against MUC.1 Antigen
    NIH R01CA077427Jul 23, 1999 - Nov 30, 2009
    Role: Principal Investigator
    ANTIGENIZED ANTIBODY AND GENE IN MALARIA VACCINE
    NIH U01AI036467Sep 15, 1994 - Aug 31, 1997
    Role: Principal Investigator
    MODULATION OF PERIPHERIAL T CELLS ACTIVITY
    NIH P01AI033204Sep 1, 1992 - Apr 30, 1996
    Role: Principal Investigator
    ENGINEERED CD4-LIKE ANTIBODIES IN NEONATAL HIV INFECTION
    NIH R01HD025787May 2, 1990 - Apr 30, 1993
    Role: Principal Investigator
    ANTIBODY V REGION REGULATION AND AUTOIMMUNITY
    NIH R01AI023871Jul 1, 1986 - Jun 30, 1990
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000827Mar 1, 1974 - Nov 30, 2010
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Integrated Germline and Somatic Features Reveal Divergent Immune Pathways Driving Response to Immune Checkpoint Blockade. Cancer Immunol Res. 2024 Dec 03; 12(12):1780-1795. Sears TJ, Pagadala MS, Castro A, Lee KH, Kong J, Tanaka K, Lippman SM, Zanetti M, Carter H. PMID: 39255339; PMCID: PMC11612627.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    2. Delivery of miR-214 via extracellular vesicles downregulates Xbp1 expression and pro-inflammatory cytokine genes in macrophages. Extracell Vesicles Circ Nucl Acids. 2024 Jun; 5(2):249-258. Almanza G, Searles S, Zanetti M. PMID: 39118980; PMCID: PMC11308798.
      View in: PubMed   Mentions:
    3. Integrated germline and somatic features reveal divergent immune pathways driving ICB response. bioRxiv. 2024 Jan 15. Sears T, Pagadala M, Castro A, Lee KH, Kong J, Tanaka K, Lippman S, Zanetti M, Carter H. PMID: 38293085; PMCID: PMC10827124.
      View in: PubMed   Mentions:
    4. Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibility. Am J Hum Genet. 2023 07 06; 110(7):1138-1161. Talwar JV, Laub D, Pagadala MS, Castro A, Lewis M, Luebeck GE, Gorman BR, Pan C, Dong FN, Markianos K, Teerlink CC, Lynch J, Hauger R, Pyarajan S, Tsao PS, Morris GP, Salem RM, Thompson WK, Curtius K, Zanetti M, Carter H. PMID: 37339630; PMCID: PMC10357503.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response. Nat Commun. 2023 05 12; 14(1):2744. Pagadala M, Sears TJ, Wu VH, Pérez-Guijarro E, Kim H, Castro A, Talwar JV, Gonzalez-Colin C, Cao S, Schmiedel BJ, Goudarzi S, Kirani D, Au J, Zhang T, Landi T, Salem RM, Morris GP, Harismendy O, Patel SP, Alexandrov LB, Mesirov JP, Zanetti M, Day CP, Fan CC, Thompson WK, Merlino G, Gutkind JS, Vijayanand P, Carter H. PMID: 37173324; PMCID: PMC10182072.
      View in: PubMed   Mentions: 14     Fields:    Translation:Cells
    6. Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer. PNAS Nexus. 2023 Mar; 2(3):pgad046. Xian S, Dosset M, Castro A, Carter H, Zanetti M. PMID: 36909826; PMCID: PMC10003760.
      View in: PubMed   Mentions: 1  
    7. Subcellular location of source proteins improves prediction of neoantigens for immunotherapy. EMBO J. 2022 12 15; 41(24):e111071. Castro A, Kaabinejadian S, Yari H, Hildebrand W, Zanetti M, Carter H. PMID: 36314681; PMCID: PMC9753441.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern. PLoS Pathog. 2022 07; 18(7):e1010686. Almanza G, Clark AE, Kouznetsova V, Olmedillas E, Castro A, Tsigelny IF, Wu Y, Gao GF, Leibel SL, Bray W, Ollmann Saphire E, Carlin AF, Zanetti M. PMID: 35862442; PMCID: PMC9302722.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCellsPHPublic Health
    9. Disulfiram's journey from rubber vulcanization to T-cell activation. EMBO J. 2022 08 16; 41(16):e111862. Dosset M, Zanetti M. PMID: 35848116; PMCID: PMC9379543.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. The Unfolded Protein Response at the Tumor-Immune Interface. Front Immunol. 2022; 13:823157. Zanetti M, Xian S, Dosset M, Carter H. PMID: 35237269; PMCID: PMC8882736.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    11. The unfolded protein response links tumor aneuploidy to local immune dysregulation. EMBO Rep. 2021 12 06; 22(12):e52509. Xian S, Dosset M, Almanza G, Searles S, Sahani P, Waller TC, Jepsen K, Carter H, Zanetti M. PMID: 34698427; PMCID: PMC8647024.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    12. Neoantigen Controversies. Annu Rev Biomed Data Sci. 2021 07 20; 4:227-253. Castro A, Zanetti M, Carter H. PMID: 34465181; PMCID: PMC10146390.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses. PLoS One. 2021; 16(2):e0246731. Castro A, Ozturk K, Zanetti M, Carter H. PMID: 33571241; PMCID: PMC7877779.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    14. MHC-II constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans. bioRxiv. 2020 Dec 28. Castro A, Ozturk K, Zanetti M, Carter H. PMID: 33398284; PMCID: PMC7781323.
      View in: PubMed   Mentions:
    15. Strength of immune selection in tumors varies with sex and age. Nat Commun. 2020 08 17; 11(1):4128. Castro A, Pyke RM, Zhang X, Thompson WK, Day CP, Alexandrov LB, Zanetti M, Carter H. PMID: 32807809; PMCID: PMC7431859.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    16. Telomerase and CD4 T Cell Immunity in Cancer. Cancers (Basel). 2020 Jun 25; 12(6). Dosset M, Castro A, Carter H, Zanetti M. PMID: 32630460; PMCID: PMC7352225.
      View in: PubMed   Mentions: 13  
    17. IRE1α regulates macrophage polarization, PD-L1 expression, and tumor survival. PLoS Biol. 2020 06; 18(6):e3000687. Batista A, Rodvold JJ, Xian S, Searles SC, Lew A, Iwawaki T, Almanza G, Waller TC, Lin J, Jepsen K, Carter H, Zanetti M. PMID: 32520957; PMCID: PMC7307794.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    18. IRE1α and IGF signaling predict resistance to an endoplasmic reticulum stress-inducing drug in glioblastoma cells. Sci Rep. 2020 05 20; 10(1):8348. Rodvold JJ, Xian S, Nussbacher J, Tsui B, Cameron Waller T, Searles SC, Lew A, Jiang P, Babic I, Nomura N, Lin JH, Kesari S, Carter H, Zanetti M. PMID: 32433555; PMCID: PMC7239929.
      View in: PubMed   Mentions: 9     Fields:    
    19. Ubi Maior Minor Cessat. Crit Rev Immunol. 2020; 40(3):255-262. Zanetti M. PMID: 33389889; PMCID: PMC11804974.
      View in: PubMed   Mentions:    Fields:    
    20. PERK-mediated induction of microRNA-483 disrupts cellular ATP homeostasis during the unfolded protein response. J Biol Chem. 2020 01 03; 295(1):237-249. Hiramatsu N, Chiang K, Aivati C, Rodvold JJ, Lee JM, Han J, Chea L, Zanetti M, Koo EH, Lin JH. PMID: 31792031; PMCID: PMC6952592.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    21. Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes. BMC Med Genomics. 2019 07 25; 12(Suppl 6):107. Castro A, Ozturk K, Pyke RM, Xian S, Zanetti M, Carter H. PMID: 31345234; PMCID: PMC6657029.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    22. Extracellular vesicles produced in B cells deliver tumor suppressor miR-335 to breast cancer cells disrupting oncogenic programming in vitro and in vivo. Sci Rep. 2018 12 04; 8(1):17581. Almanza G, Rodvold JJ, Tsui B, Jepsen K, Carter H, Zanetti M. PMID: 30514916; PMCID: PMC6279829.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    23. Evolutionary Pressure against MHC Class II Binding Cancer Mutations. Cell. 2018 10 04; 175(2):416-428.e13. Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H. PMID: 30245014; PMCID: PMC6482006.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansAnimalsCells
    24. Insidious communication amongst cancer cells. Mol Cell Oncol. 2018; 5(3):e1356898. Rodvold JJ, Zanetti M. PMID: 30250884; PMCID: PMC6149878.
      View in: PubMed   Mentions:
    25. Cripto stabilizes GRP78 on the cell membrane. Protein Sci. 2018 03; 27(3):653-661. Kouznetsova VL, Hu H, Teigen K, Zanetti M, Tsigelny IF. PMID: 29226519; PMCID: PMC5818753.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    26. A community affair in the tumor microenvironment. Oncotarget. 2017 Dec 05; 8(63):106173-106174. Rodvold JJ, Kesari S, Zanetti M. PMID: 29290938; PMCID: PMC5739723.
      View in: PubMed   Mentions: 1     Fields:    
    27. Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells. Sci Signal. 2017 Jun 06; 10(482). Rodvold JJ, Chiu KT, Hiramatsu N, Nussbacher JK, Galimberti V, Mahadevan NR, Willert K, Lin JH, Zanetti M. PMID: 28588081; PMCID: PMC5962022.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    28. Chromosomal chaos silences immune surveillance. Science. 2017 01 20; 355(6322):249-250. Zanetti M. PMID: 28104855.
      View in: PubMed   Mentions: 9     Fields:    
    29. Tumor microenvironment on the move and the Aselli connection. Sci Signal. 2016 06 28; 9(434):fs13. Rodvold JJ, Zanetti M. PMID: 27353363.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    30. A second chance for telomerase reverse transcriptase in anticancer immunotherapy. Nat Rev Clin Oncol. 2017 02; 14(2):115-128. Zanetti M. PMID: 27245281.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    31. High-efficiency Generation of Multiple Short Noncoding RNA in B-cells and B-cell-derived Extracellular Vesicles. Mol Ther Nucleic Acids. 2015 Dec 15; 4:e271. Almanza G, Zanetti M. PMID: 26670278; PMCID: PMC5014536.
      View in: PubMed   Mentions: 3  
    32. Immune modulation by ER stress and inflammation in the tumor microenvironment. Cancer Lett. 2016 09 28; 380(1):227-36. Rodvold JJ, Mahadevan NR, Zanetti M. PMID: 26525580.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    33. Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics. J Immunol. 2015 Mar 01; 194(5):2049-56. Zanetti M. PMID: 25710958.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    34. Synthesis and delivery of short, noncoding RNA by B lymphocytes. Proc Natl Acad Sci U S A. 2013 Dec 10; 110(50):20182-7. Almanza G, Anufreichik V, Rodvold JJ, Chiu KT, DeLaney A, Akers JC, Chen CC, Zanetti M. PMID: 24277816; PMCID: PMC3864290.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    35. A Janus-faced role of the unfolded protein response in antitumor immunity. Oncoimmunology. 2013 May 01; 2(5):e23901. Mahadevan NR, Rodvold JJ, Zanetti M. PMID: 23762789; PMCID: PMC3667895.
      View in: PubMed   Mentions: 3     Fields:    
    36. Cell-extrinsic effects of the tumor unfolded protein response on myeloid cells and T cells. Ann N Y Acad Sci. 2013 May; 1284:6-11. Zanetti M. PMID: 23651187.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    37. Sensing hyperploidy and immune surveillance: a pas-de-deux. Cell Cycle. 2013 Feb 15; 12(4):544-5. Mahadevan NR, Zanetti M. PMID: 23370385; PMCID: PMC3594253.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    38. Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming. PLoS One. 2012; 7(12):e51845. Mahadevan NR, Anufreichik V, Rodvold JJ, Chiu KT, Sepulveda H, Zanetti M. PMID: 23272178; PMCID: PMC3525659.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansAnimalsCells
    39. Activation of the unfolded protein response bypasses trastuzumab-mediated inhibition of the PI-3K pathway. Cancer Lett. 2013 Feb 28; 329(2):236-42. Kumandan S, Mahadevan NR, Chiu K, DeLaney A, Zanetti M. PMID: 23200669; PMCID: PMC4091625.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    40. Cancer. Immune surveillance from chromosomal chaos? Science. 2012 Sep 28; 337(6102):1616-7. Zanetti M, Mahadevan NR. PMID: 23019639.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    41. Lipocalin 2 in cancer: when good immunity goes bad. Cancer Lett. 2012 Mar 28; 316(2):132-8. Rodvold JJ, Mahadevan NR, Zanetti M. PMID: 22075378.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimals
    42. Tumor stress inside out: cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment. J Immunol. 2011 Nov 01; 187(9):4403-9. Mahadevan NR, Zanetti M. PMID: 22013206; PMCID: PMC11299296.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    43. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner. BMC Cancer. 2011 Jun 07; 11:229. Mahadevan NR, Rodvold J, Almanza G, Pérez AF, Wheeler MC, Zanetti M. PMID: 21649922; PMCID: PMC3146445.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    44. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. Proc Natl Acad Sci U S A. 2011 Apr 19; 108(16):6561-6. Mahadevan NR, Rodvold J, Sepulveda H, Rossi S, Drew AF, Zanetti M. PMID: 21464300; PMCID: PMC3081038.
      View in: PubMed   Mentions: 145     Fields:    Translation:AnimalsCells
    45. Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones. Cell Immunol. 2010; 266(1):1-6. Franco A, Almanza G, Burns JC, Wheeler M, Zanetti M. PMID: 20951371.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    46. Prostate cancer cells undergoing ER stress in vitro and in vivo activate transcription of pro-inflammatory cytokines. J Inflamm Res. 2010; 3:99-103. Mahadevan NR, Fernandez A, Rodvold JJ, Almanza G, Zanetti M. PMID: 22096360; PMCID: PMC3218737.
      View in: PubMed   Mentions: 11  
    47. Selected microRNAs define cell fate determination of murine central memory CD8 T cells. PLoS One. 2010 Jun 22; 5(6):e11243. Almanza G, Fernandez A, Volinia S, Cortez-Gonzalez X, Croce CM, Zanetti M. PMID: 20582165; PMCID: PMC2889817.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    48. Principles of memory CD8 T-cells generation in relation to protective immunity. Adv Exp Med Biol. 2010; 684:108-25. Zanetti M, Castiglioni P, Ingulli E. PMID: 20795544.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    49. Identification of immunogenic peptides of the self-tumor antigen: our experience with telomerase reverse transcriptase. Methods Mol Biol. 2010; 651:211-25. Cortez-Gonzalez X, Zanetti M. PMID: 20686968.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    50. Cutting edge: antigen presentation to CD8 T cells after influenza A virus infection. J Immunol. 2009 Jan 01; 182(1):29-33. Ingulli E, Funatake C, Jacovetty EL, Zanetti M. PMID: 19109130.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    51. KDEL-retained antigen in B lymphocytes induces a proinflammatory response: a possible role for endoplasmic reticulum stress in adaptive T cell immunity. J Immunol. 2008 Jul 01; 181(1):256-64. Wheeler MC, Rizzi M, Sasik R, Almanza G, Hardiman G, Zanetti M. PMID: 18566391.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    52. Protection against influenza A virus by memory CD8 T cells requires reactivation by bone marrow-derived dendritic cells. J Immunol. 2008 Apr 01; 180(7):4956-64. Castiglioni P, Hall de S, Jacovetty EL, Ingulli E, Zanetti M. PMID: 18354221.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    53. Plasmid DNA and IL-4 modulate expression of mHC class I and costimulatory molecules in B lymphocytes. DNA Cell Biol. 2007 Mar; 26(3):148-59. Frazzi R, Zanetti M. PMID: 17417943.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    54. Telomerase immunity from bench to bedside: round one. J Transl Med. 2007 Feb 26; 5:12. Cortez-Gonzalez X, Zanetti M. PMID: 17324292; PMCID: PMC1839079.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    55. Immunity and protection, the unfolding of a tale. Immunol Res. 2007; 38(1-3):305-18. Zanetti M. PMID: 17917038.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    56. Immunogenic HLA-B7-restricted peptides of hTRT. Int Immunol. 2006 Dec; 18(12):1707-18. Cortez-Gonzalez X, Sidney J, Adotevi O, Sette A, Millard F, Lemonnier F, Langlade-Demoyen P, Zanetti M. PMID: 17077179.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    57. T cell memory and protective immunity by vaccination: is more better? Trends Immunol. 2006 Nov; 27(11):511-7. Zanetti M, Franchini G. PMID: 16997631.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    58. Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines. Immunology. 2006 Sep; 119(1):98-115. Koch KS, Son KH, Maehr R, Pellicciotta I, Ploegh HL, Zanetti M, Sell S, Leffert HL. PMID: 16836618; PMCID: PMC1782333.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    59. TLR9-independent activation of B lymphocytes by bacterial DNA. DNA Cell Biol. 2006 May; 25(5):253-61. Cortez-Gonzalez X, Pellicciotta I, Gerloni M, Wheeler MC, Castiglioni P, Lenert P, Zanetti M. PMID: 16716115.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    60. Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation. Int Rev Immunol. 2006 May-Aug; 25(3-4):83-97. Wheeler M, Cortez-Gonzalez X, Frazzi R, Zanetti M. PMID: 16818366.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    61. The cooperation between two CD4 T cells induces tumor protective immunity in MUC.1 transgenic mice. J Immunol. 2005 Nov 15; 175(10):6551-9. Gerloni M, Castiglioni P, Zanetti M. PMID: 16272309.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    62. T for two: when helpers need help. Autoimmun Rev. 2005 Nov; 4(8):571-8. Zanetti M. PMID: 16214098.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    63. In utero DNA immunisation. Immunity over tolerance in fetal life. Vaccine. 2005 Jul 21; 23(33):4273-82. Rizzi M, Gerloni M, Srivastava AS, Wheeler MC, Schuler K, Carrier E, Zanetti M. PMID: 16005117.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsPHPublic Health
    64. CD8 T cell priming by B lymphocytes is CD4 help dependent. Eur J Immunol. 2005 May; 35(5):1360-70. Castiglioni P, Gerloni M, Cortez-Gonzalez X, Zanetti M. PMID: 15816014.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    65. CD4 T cells in tumor immunity. Springer Semin Immunopathol. 2005 Jun; 27(1):37-48. Gerloni M, Zanetti M. PMID: 15965712.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    66. Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans. Springer Semin Immunopathol. 2005 Jun; 27(1):87-104. Zanetti M, Hernandez X, Langlade-Demoyen P. PMID: 15711953.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    67. Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells. Vaccine. 2004 Dec 16; 23(5):699-708. Castiglioni P, Gerloni M, Zanetti M. PMID: 15542193.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    68. Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis. J Immune Based Ther Vaccines. 2004 Nov 12; 2(1):9. Musselli C, Daverio-Zanetti S, Zanetti M. PMID: 15541175; PMCID: PMC539290.
      View in: PubMed   Mentions:
    69. Antigenicity and immunogenicity of peptide analogues of a low affinity peptide of the human telomerase reverse transcriptase tumor antigen. Eur J Immunol. 2004 Aug; 34(8):2331-41. Hernández J, Schoeder K, Blondelle SE, Pons FG, Lone YC, Simora A, Langlade-Demoyen P, Wilson DB, Zanetti M. PMID: 15259031.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    70. B lymphocytes as antigen-presenting cell-based genetic vaccines. Immunol Rev. 2004 Jun; 199:264-78. Zanetti M, Castiglioni P, Rizzi M, Wheeler M, Gerloni M. PMID: 15233740.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    71. T cell immunity using transgenic B lymphocytes. Proc Natl Acad Sci U S A. 2004 Mar 16; 101(11):3892-7. Gerloni M, Rizzi M, Castiglioni P, Zanetti M. PMID: 15004284; PMCID: PMC374340.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    72. The role of relB in regulating the adaptive immune response. Ann N Y Acad Sci. 2003 Apr; 987:249-57. Zanetti M, Castiglioni P, Schoenberger S, Gerloni M. PMID: 12727647.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    73. CD4 T cell priming in dendritic cell-deficient mice. Int Immunol. 2003 Jan; 15(1):127-36. Castiglioni P, Lu C, Lo D, Croft M, Langlade-Demoyen P, Zanetti M, Gerloni M. PMID: 12502733.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    74. Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells. Proc Natl Acad Sci U S A. 2002 Sep 17; 99(19):12275-80. Hernandez J, Garcia-Pons F, Lone YC, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M. PMID: 12218171; PMCID: PMC129435.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    Maurizio's Networks
    Concepts (302)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (31)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-12-gbedcc43d on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California